UBS Group upgraded shares of Vylor (NYSE:VYLR – Free Report) to a strong-buy rating in a report issued on Monday,Zacks reports.
Other research analysts have also recently issued reports about the company. BMO Capital Markets initiated coverage on Vylor in a research note on Friday, October 2nd. They issued an “outperform” rating and a $85.00 target price for the company. Wall Street Zen raised Vylor to a “sell” rating in a research report on Saturday. Zacks Research upgraded Vylor to a “hold” rating in a report on Monday, October 5th. Morgan Stanley started coverage on Vylor in a research report on Friday, October 2nd. They issued an “overweight” rating and a $85.00 price objective for the company. Finally, Wolfe Research upgraded Vylor to a “strong-buy” rating in a research report on Thursday, October 1st. Three investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $83.36.
View Our Latest Stock Report on Vylor
Vylor Trading Up 0.9%
About Vylor
Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.
Featured Articles
- Five stocks we like better than Vylor
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.
